Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17463324 | 0.93 | L3MBTL1 (0.46) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17463346 | 0.93 | L3MBTL1 (0.41) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17463331 | 0.93 | L3MBTL1 (0.41) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17461191 | 0.88 | L3MBTL1 (0.53) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL19870210 | 0.87 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17461228 | 0.86 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17463339 | 0.85 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17463328 | 0.85 | L3MBTL1 (0.42) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17463294 | 0.85 | L3MBTL1 (0.42) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL17461169 | 0.84 | KDM4E (0.45) | L3MBTL1ATMKDM4EKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2016-01-28 | — | — | US | disclosed |
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CCNE1 | L3MBTL1 863/4885ATM 1164/4885KDM4E 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.